Valvular & structural heart diseaseCohort study

Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis

CirculationPublished

  • Retrospective cohort study
  • multicentre (29 centres)
  • propensity-score matched
  • multiple imputation
  • doubly robust adjustment

Authors' conclusion

In patients undergoing transcatheter aortic valve replacement for bicuspid aortic valve stenosis, death or stroke does not significantly differ between those receiving a BE-THV and those receiving an SE-THV over a follow-up of 3 years.

Study context

Population
Consecutive patients undergoing TAVR for CT-diagnosed bicuspid aortic valve stenosis
Participants
1,443 patients · 29 centres
Exposure
TAVR with balloon-expandable vs self-expandable THV
  • BE-THVn = 860
  • SE-THVn = 583reference
Outcome
Death or stroke
Follow-up
3 years

Main finding

As reported in the abstract

Hazard ratio

0.99

95% CI 0.65–1.51

By group

BE-THV vs SE-THV
HR 0.99 (95% CI 0.65–1.51)

Observational data: associations, not effects.

Further findings

OutcomeBE-THVSE-THVHR (95% CI)
In-hospital and 30-day death or stroke · after propensity score matching5.1%6.1%1.02 (0.51–2.02)

Death or stroke across clinical, anatomical, functional and procedural subgroups

Consistent with the main analysis

Safety

OutcomeBE-THVSE-THVHR (95% CI)
Pacemaker implantation · 30 days · after propensity score matching11.9%18.6%0.58 (0.36–0.93)

Procedural complications

BE-THV: higher annulus rupture and mean transvalvular gradient
SE-THV: higher additional valve implantation and paravalvular regurgitation

Original publication

Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis. Circulation. Published 18 August 2025. doi:10.1161/circulationaha.124.069323

Summarised from the published abstract; every number is checked against it